Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan‐Smith, E., Dalton, J., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,777

Acute lymphoblastic leukaemia

Pui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072

The ikaros gene is required for the development of all lymphoid lineages

Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., & Sharpe, A. (1994) · Cell · doi:10.1016/0092-8674(94)90407-3 · Cited by 985

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

Borowitz, M. J., Devidas, M., Hunger, S. P., Bowman, W. P., Carroll, A. J., Carroll, W. L., Linda, S. B., Martin, P. L., Pullen, D. J., Viswanatha, D. S., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132837 · Cited by 841

Prediction by Supervised Principal Components

Bair, E., Hastie, T. J., Paul, D., & Tibshirani, R. J. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000000628 · Cited by 824

Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia

Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806

On testing the significance of sets of genes

Efron, B., & Tibshirani, R. J. (2007) · The Annals of Applied Statistics · doi:10.1214/07-aoas101 · Cited by 785

Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data

Bair, E., & Tibshirani, R. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020108 · Cited by 749

Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia

McGregor, S. M., McNeer, J. L., & Gurbuxani, S. K. (2012) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.07.004 · Cited by 29

Genomic Characterization of Acute Leukemias

Chiaretti, S., Gianfelici, V., Ceglie, G., & Foà, R. (2014) · Medical Principles and Practice · doi:10.1159/000362793 · Cited by 32

The Promise and the Reality of Genomics to Guide Precision Medicine in Pediatric Oncology: The Decade Ahead

Evans, W. E., Pui, C., & Yang, J. J. J. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1660 · Cited by 31

Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia

Gavralidis, A., & Brunner, A. M. (2020) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-020-00591-4 · Cited by 29

IKAROS Family Zinc Finger 1–Associated Diseases in Primary Immunodeficiency Patients

Nunes-Santos, C. J., Kuehn, H. S., & Rosenzweig, S. D. (2020) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2020.04.004 · Cited by 29

Philadelphia-Like Acute Lymphoblastic Leukemia: A Systematic Review

Yadav, V., Ganesan, P., Veeramani, R., & Kumar, D. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.08.011 · Cited by 29

DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia

Rehn, J. A., O'Connor, M. J., White, D. L., & Yeung, D. T. O. (2020) · Cancers · doi:10.3390/cancers12102815 · Cited by 29

Pharmacogenomics of intracellular methotrexate polyglutamates in patients’ leukemia cells in vivo

López-López, E., Autry, R. J., Smith, C. J., Yang, W., Paugh, S. W., Panetta, J. C., Crews, K. R., Bonten, E. J., Smart, B., Pei, D., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140797 · Cited by 29

Double sword role of EZH2 in leukemia

Safaei, S., Baradaran, B., Hagh, M. F., Alivand, M. R., Talebi, M., Gharibi, T., & Solali, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.059 · Cited by 29

Targeted therapy for fusion-driven high-risk acute leukemia

Pikman, Y., & Stegmaier, K. (2018) · Blood · doi:10.1182/blood-2018-04-784157 · Cited by 29

Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies

Scheijen, B. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.29 · Cited by 29

Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia

(2009) · New England Journal of Medicine · doi:10.1056/nejmc090454 · Cited by 29

IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia

Paolino, J. D., Tsai, H. K., Harris, M. H., & Pikman, Y. (2024) · Biomedicines · doi:10.3390/biomedicines12010089 · Cited by 30

Novel agents and biomarkers for acute lymphoid leukemia

Zhao, Y., Huang, H., & Wei, G. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-40 · Cited by 28

B‐cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification

Yeung, D. T. O., Osborn, M. P., & White, D. L. (2021) · British Journal of Haematology · doi:10.1111/bjh.17879 · Cited by 29

Minimal residual disease

Campana, D. (2012) · Leukemia Supplements · doi:10.1038/leusup.2012.5 · Cited by 28

Prognostic significance of MSI 2 predicts unfavorable outcome in adult B‐acute lymphoblastic leukemia

Aly, R., & Ghazy, H. F. A.-E. H. (2014) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12284 · Cited by 28

Acute Lymphoblastic Leukemia — On the Wings of IKAROS

Georgopoulos, K. (2009) · New England Journal of Medicine · doi:10.1056/nejme0809819 · Cited by 28

Laboratory testing in BCR‐ABL1‐like (Philadelphia‐like) B‐lymphoblastic leukemia/lymphoma

Siegele, B. J., & Nardi, V. (2018) · American Journal of Hematology · doi:10.1002/ajh.25126 · Cited by 27

Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia

Iacobucci, I., & Roberts, K. G. (2021) · Genes · doi:10.3390/genes12050687 · Cited by 27

MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data

Cmero, M., Schmidt, B., Majewski, I. J., Ekert, P. G., Oshlack, A., & Davidson, N. (2021) · Genome biology · doi:10.1186/s13059-021-02507-8 · Cited by 28

Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia

Ghazavi, F., Lammens, T., Roy, N. V., Poppe, B. G., Speleman, F., Benoît, Y., Vlierberghe, P. V., & Moerloose, B. D. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.015 · Cited by 30

Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL‐negative acute lymphoblastic leukemia

Volejníková, J., Mejstříková, E., Dörge, P., Meissner, B., Zimmermannová, O., Švojgr, K., Stanulla, M., Cario, G., Schrappe, M., Starý, J., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24299 · Cited by 27

Angiopoietin-Like Protein 3 Promotes Preservation of Stemness during Ex Vivo Expansion of Murine Hematopoietic Stem Cells

Farahbakhshian, E., Verstegen, M. M. A., Visser, T. P., Kheradmandkia, S., Geerts, D., Arshad, S., Riaz, N., Grosveld, F. G., van Til, N. P., & Meijerink, J. P. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105642 · Cited by 27

Multiple functions of Ikaros in hematological malignancies, solid tumor and autoimmune diseases

Chen, Q., Shi, Y., Chen, Y., Ji, T., Li, Y., & Yu, L. (2018) · Gene · doi:10.1016/j.gene.2018.10.045 · Cited by 27

Cellular signaling and epigenetic regulation of gene expression in leukemia

Gowda, C. S., Song, C., Ding, Y., Iyer, S., Dhanyamraju, P. K., McGrath, M., Bamme, Y., Soliman, M., Kane, S., Payne, J. L., et al. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.100665 · Cited by 27

Current status of gene expression profiling in the diagnosis and management of acute leukaemia

Bacher, U., Kohlmann, A., & Haferlach, T. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07656.x · Cited by 28

Increased post‐induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 109/l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the C hildren's O ncology G roup

Hastings, C. A., Gaynon, P. S., Nachman, J. B., Sather, H. N., Lu, X., Devidas, M., & Seibel, N. L. (2014) · British Journal of Haematology · doi:10.1111/bjh.13160 · Cited by 27

The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia

Verbeek, M. W. C., & van der Velden, V. H. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094881 · Cited by 26

High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia

Othman, M. A. K., Melo, J. B., Carreira, I. M., Rinčić, M., Glaser, A., Grygalewicz, B., Gruhn, B., Wilhelm, K., Rittscher, K., Meyer, B., et al. (2015) · Molecular Cytogenetics · doi:10.1186/s13039-015-0153-4 · Cited by 26

Relapse of Acute Lymphoblastic Leukemia in Children in the Context of Microarray Analyses

Szczepanek, J., Styczyński, J., Haus, O., Tretyn, A., & Wysocki, M. S. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0110-1 · Cited by 26

Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia

Heltemes-Harris, L. M., Larson, J. D., Starr, T. K., Hubbard, G. K., Sarver, A. L., Largaespada, D. A., & Farrar, M. A. (2015) · Oncogene · doi:10.1038/onc.2015.405 · Cited by 29

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults

Herold, T., & Gökbuget, N. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0589-2 · Cited by 26

Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia

Cho, H., Kim, Y., Yoon, J., Lee, J., Lee, D., Son, J., Han, K., Lee, S., & Kim, M. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01253-6 · Cited by 26

X-Linked Agammaglobulinemia Associated with B-Precursor Acute Lymphoblastic Leukemia

Hoshino, A., Okuno, Y., Migita, M., Ban, H., Yang, X., Kiyokawa, N., Adachi, Y., Kojima, S., Ohara, O., & Kanegane, H. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0127-7 · Cited by 26

Transcriptional Control of Pre-B Cell Development and Leukemia Prevention

Pang, S. H. M., Carotta, S., & Nutt, S. L. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_377 · Cited by 28

Ikaros: master of hematopoiesis, agent of leukemia

Davis, K. L. (2011) · Therapeutic Advances in Hematology · doi:10.1177/2040620711412419 · Cited by 26

‘Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting

Gupta, D. G., Varma, N., Sreedharanunni, S., Abdulkadir, S. A., Naseem, S., Sachdeva, M. U. S., Binota, J., Bose, P. L., Malhotra, P., Khadwal, A., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02294-y · Cited by 25

Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts

Theocharides, A. P. A., Dobson, S. M., Laurenti, E., Notta, F., Voisin, V., Cheng, P.-Y., Yuan, J. S., Guidos, C. J., Minden, M. D., Mullighan, C. G., et al. (2014) · Leukemia · doi:10.1038/leu.2014.150 · Cited by 25

MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia

Yu, C., Lin, T.-K., Jou, S., Lin, C., Lin, K., Lu, M., Chen, S., Cheng, C., Wu, K., Wang, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68311-9 · Cited by 25

B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

Ratti, S., Lonetti, A., Follo, M. Y., Paganelli, F., Martelli, A. M., Chiarini, F., & Evangelisti, C. (2020) · Cancers · doi:10.3390/cancers12123498 · Cited by 27

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

Fazio, G., Bresolin, S., Silvestri, D., Quadri, M., Saitta, C., Vendramini, E., Buldini, B., Palmi, C., Bardini, M., Grioni, A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104224 · Cited by 25

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance

Vitanza, N. A., Zaky, W. T., Blum, R., Meyer, J. A., Wang, J., Bhatla, T., Morrison, D. J., Raetz, E. A., & Carroll, W. L. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25119 · Cited by 25

Prognostic impact of IKZF1 deletions in association with vincristine–dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95

Hinze, L., Möricke, A., Zimmermann, M., Junk, S. V., Cario, G., Dağdan, E., Kratz, C. P., Conter, V., Schrappe, M., & Stanulla, M. (2017) · Leukemia · doi:10.1038/leu.2017.154 · Cited by 25

Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia

Potter, N. E., Jones, L., Blair, H. J., Strehl, S., Harrison, C. J., Greaves, M. F., Kearney, L., & Russell, L. J. (2018) · Leukemia · doi:10.1038/s41375-018-0297-4 · Cited by 25

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

Kim, M., Park, J., Kim, D.-W., Kim, Y., Jeon, Y.-W., Yoon, J.-H., Shin, S.-H., Yahng, S.-A., Lee, S. U., Cho, B.-S., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.281 · Cited by 25

TEL (ETV6)‐AML1 (RUNX1) Initiates Self‐Renewing Fetal Pro‐B Cells in Association with a Transcriptional Program Shared with Embryonic Stem Cells in Mice

Tsuzuki, S., & Seto, M. (2013) · Stem Cells · doi:10.1002/stem.1277 · Cited by 26

IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population

Bahari, G., Hashemi, M. M., Naderi, M., & Taheri, M. (2016) · Tumor Biology · doi:10.1007/s13277-016-4853-0 · Cited by 24

A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics

Sánchez, R., Ribera, J., Morgades, M., Ayala, R. M., Onecha, E., Ruiz‐Heredia, Y., Juárez-Rufián, A., de Nicolás, R., Sánchez‐Pina, J. M., Vives, S., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0308-3 · Cited by 24

Clinical screening for Ph-like ALL and the developing role of TKIs

Tran, T. H., & Tasian, S. K. (2022) · Hematology · doi:10.1182/hematology.2022000357 · Cited by 24

A Health-Care System Perspective on Implementing Genomic Medicine: Pediatric Acute Lymphoblastic Leukemia as a Paradigm

Evans, W. E., Crews, K. R., & Pui, C.-H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.9 · Cited by 24

Management strategies in acute lymphoblastic leukemia.

Rabin, K. R., & Poplack, D. G. (2011) · PubMed · Cited by 24

Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis

Welsh, S. J., Churchman, M. L., Togni, M., Mullighan, C. G., & Hagman, J. R. (2017) · Leukemia · doi:10.1038/leu.2017.166 · Cited by 24

Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia

Akkari, Y. M. N., Bruyèrè, H., Hagelstrom, R. T., Kanagal‐Shamanna, R., Liu, J., Luo, M., Mikhail, F. M., Pitel, B. A., Raca, G., Shago, M., et al. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.03.001 · Cited by 24

Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers

He, B., Gao, P., Ding, Y., Chen, C.-H., Chen, G., Chen, C., Kim, H., Tasian, S. K., Hunger, S. P., & Tan, K. (2020) · Science Advances · doi:10.1126/sciadv.aba3064 · Cited by 25

Blood-based transcriptomics: leukemias and beyond

Staratschek‐Jox, A., Claßen, S., Gaarz, A., Debey‐Pascher, S., & Schultze, J. L. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.9 · Cited by 24

Real-time genomic characterization of pediatric acute leukemia using adaptive sampling

Geyer, J. K., Opoku, K. B., Lin, J., Ramkissoon, L. A., Mullighan, C. G., Bhakta, N. H., Alexander, T., & Wang, J. (2025) · Leukemia · doi:10.1038/s41375-025-02565-y · Cited by 23

IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL

Simonin, M., Lhermitte, L., Dourthe, M.-É., Lengliné, É., Graux, C., Grardel, N., Cayuela, J., Arnoux, I., Gandemer, V., Ifrah, N., et al. (2020) · Blood · doi:10.1182/blood.2020007959 · Cited by 23

Genomic and proteomic characterization of Philadelphia‐like B‐lineage acute lymphoblastic leukemia: A report of Indian patients

Gupta, D. G., Varma, N., Kumar, A., Naseem, S., Sachdeva, M. U. S., Sreedharanunni, S., Binota, J., Bose, P. L., Khadwal, A., Malhotra, P., et al. (2023) · Cancer · doi:10.1002/cncr.34665 · Cited by 23

High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia

Oikonomou, A., Valsecchi, L., Quadri, M., Watrin, T., Scharov, K., Procopio, S., Tu, J., Vogt, M., Savino, A. M., Silvestri, D., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115809 · Cited by 23

How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia

Roberts, K. G., & Mullighan, C. G. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283426260 · Cited by 23

Cooperative genetic changes in pediatric B‐cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1

Olsson, L., Albitar, F. S., Castor, A., Behrendtz, M., Biloglav, A., Paulsson, K. M., & Johansson, B. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22245 · Cited by 23

Personalized medicine in adult acute lymphoblastic leukemia

Hoelzer, D. T. (2015) · Haematologica · doi:10.3324/haematol.2015.127837 · Cited by 23

Recent advances in the management of pediatric acute lymphoblastic leukemia

Starý, J., & Hrušák, O. (2016) · F1000Research · doi:10.12688/f1000research.9548.1 · Cited by 23

Novel Therapies in Acute Lymphoblastic Leukemia

Faderl, S. H., & Kantarjian, H. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-72304-2_19 · Cited by 22

Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance

Nowak, D., Liem, N. L. M., Mossner, M., Klaumuenzer, M., Papa, R. A., Nowak, V., Jann, J. C., Akagi, T., Kawamata, N., Okamoto, R., et al. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.09.007 · Cited by 22

Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children

Hsu, L., Chokkalingam, A. P., Briggs, F. B. S., Walsh, K. M., Crouse, V. L., Fu, C. H., Metayer, C., Wiemels, J. L., Barcellos, L. F., & Buffler, P. A. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0550-3 · Cited by 22

Genes at the Crossroad of Primary Immunodeficiencies and Cancer

Derpoorter, C., Bordon, V., Laureys, G., Haerynck, F., & Lammens, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02544 · Cited by 23

Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia

Zaliova, M. K., Potůčková, E., Lukes, J., Winkowska, L., Starková, J., Janotová, I., Šrámková, L., Starý, J., Zuna, J., Stanulla, M., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.249094 · Cited by 22

IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia

Maciel, A. L. T., Barbosa, T. C., Blunck, C. B., Wolch, K., Machado, A. D. A. L., da Costa, E. S., Bergier, L. L., Schramm, M., Ikoma, M. R. V., Lins, M. M., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101291 · Cited by 22

Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory

Hu, Z., Kovach, A. E., Yellapantula, V. D., Ostrow, D. G., Doan, A., Ji, J., Schmidt, R. J., Gu, Z., Bhojwani, D., & Raca, G. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.09.013 · Cited by 22

In Utero Origins of Acute Leukemia in Children

de Smith, A. J., & Spector, L. G. (2024) · Biomedicines · doi:10.3390/biomedicines12010236 · Cited by 22

Protein Phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros‐mediated repression of TdT in thymocytes and T‐cell leukemia

Wang, H., Song, C., Gürel, Z., Song, N., Ma, J., Ouyang, H., Lai, L., Payne, K. J., & Dovat, S. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25221 · Cited by 22

Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia

Urayama, K. Y., Chokkalingam, A. P., Manabe, A., & Mizutani, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1220-9 · Cited by 22

Human factors and pathways essential for mediating epigenetic gene silencing

Poleshko, A. S., Kossenkov, A. V., Shalginskikh, N., Pecherskaya, A., Pecherskaya, A., Einarson, M. B., Einarson, M. B., Skalka, A. M., Skalka, A. M., Katz, R. A., et al. (2014) · Epigenetics · doi:10.4161/epi.32088 · Cited by 22

Microarray‐based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia

Simons, A., Stevens‐Kroef, M., Idrissi‐Zaynoun, N. E., van Gessel, S., Weghuis, D. O., van den Berg, E., Waanders, E., Hoogerbrugge, P. M., Kuiper, R. P., & van Kessel, A. G. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20919 · Cited by 22

Philadelphia-like acute lymphoblastic leukemia: diagnostic dilemma and management perspectives

Kotb, A. N., Fakih, R. O. E., Hanbali, A. S., Hawsawi, Y. M., Alfraih, F. A., Hashmi, S. K., & Aljurf, M. D. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.07.007 · Cited by 22

Genetic Testing in the Diagnosis and Biology of Acute Leukemia

Harris, M. H., Czuchlewski, D. R., Arber, D. A., & Czader, M. (2019) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz093 · Cited by 22

Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next‐generation sequencing approaches

Kim, B., Kim, E., Lee, S., Cheong, J., Lyu, C. J., Min, Y. H., & Choi, J. R. (2019) · Hematological Oncology · doi:10.1002/hon.2709 · Cited by 22

Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations

Antić, Ž., Yu, J., van Reijmersdal, S. V., van Dijk, A. H. A., Dekker, L., Segerink, W. H., Sonneveld, E., Fiocco, M. F., Pieters, R., Hoogerbrugge, P. M., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.259226 · Cited by 22

Inborn errors of IKAROS and AIOLOS

Yamashita, M., & Morio, T. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.06.010 · Cited by 22

Absence of biallelic TCR γ deletion predicts induction failure and poorer outcomes in childhood T‐cell acute lymphoblastic leukemia

Yang, Y., Hsiao, C., Chen, H., Lin, K., Jou, S., Chen, J., Chang, T., Sheen, J., Yu, S., Lu, M., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24021 · Cited by 22

Transcription factor networks link B-lymphocyte development and malignant transformation in leukemiaPreprint

Sigvardsson, M. (2023) · Genes & Development · doi:10.1101/gad.349879.122 · Cited by 24

Determination of ETV 6‐ RUNX 1 genomic breakpoint by next‐generation sequencing

Jin, Y., Wang, X., Hu, S., Tang, J., Li, B., & Chai, Y.-H. (2015) · Cancer Medicine · doi:10.1002/cam4.579 · Cited by 21

Have any strategies in Ph-like ALL been shown to be effective?

Aldoss, I. T., & Advani, A. S. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101242 · Cited by 21

Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia

Ge, Z., Song, C., Ding, Y., Tan, B., Desai, D. H., Sharma, A. K., Gowda, R., Yue, F., Huang, S., Spiegelman, V. S., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01132-5 · Cited by 21

Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2- rearranged Ph-like ALL

Sasaki, K., Yamauchi, T., Semba, Y., Nogami, J., Imanaga, H., Terasaki, T., Nakao, F., Akahane, K., Inukai, T., Verhoeyen, E., et al. (2021) · Blood · doi:10.1182/blood.2021012976 · Cited by 21

The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21)

Kaczmarska, A., Derebas, J., Pinkosz, M., Niedźwiecki, M., & Lejman, M. (2023) · Cells · doi:10.3390/cells12030357 · Cited by 21

Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators

Barnett, K. R., Mobley, R. J., Diedrich, J. D., Bergeron, B. P., Bhattarai, K. R., Monovich, A. C., Narina, S., Yang, W., Crews, K. R., Manring, C. S., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100442 · Cited by 22

Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant

Richmond, J., Robbins, A. K., Evans, K., Beck, D., Kurmasheva, R. T., Billups, C. A., Carol, H., Heatley, S. L., Sutton, R., Marshall, G. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0523 · Cited by 26

Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL)

Yap, K. L., Furtado, L. V., Kiyotani, K., Curran, E. K., Stock, W., McNeer, J. L., Kadri, S., Segal, J. P., Nakamura, Y., Beau, M. M. L., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1219902 · Cited by 21

Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options

Khan, M., Siddiqi, R. L., & Tran, T. H. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.05.001 · Cited by 23

Prognostic significance of IKZF1 deletions and IKZF1 plus profile in children with B‐cell precursor acute lymphoblastic leukemia treated according to the ALL‐IC BFM 2009 protocol

Braun, M., Pastorczak, A. K., Sędek, Ł., Taha, J., Madzio, J., Jatczak‐Pawlik, I., Wypyszczak, K., Matysiak, M. J., Derwich, K., Lejman, M., et al. (2022) · Hematological Oncology · doi:10.1002/hon.2973 · Cited by 21

Genome-Wide Mapping Of Copy Number Variations using SNP Arrays

Nowak, D., Hofmann, W., & Koeffler, H. P. (2009) · Transfusion Medicine and Hemotherapy · doi:10.1159/000225372 · Cited by 21

Cytogenetics of Acute Leukemia

Heerema, N. A., & Raimondi, S. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_18 · Cited by 21

Leucemia linfoblástica aguda infantil: una aproximación genómica

Jiménez‐Morales, S., Hidalgo‐Miranda, A., & Ramírez‐Bello, J. (2017) · Boletín Médico del Hospital Infantil de México · doi:10.1016/j.bmhimx.2016.07.007 · Cited by 21

PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1 -like acute lymphoblastic leukaemia in Indian patients

Gupta, D. G., Varma, N., Kumar, A., Naseem, S., Sachdeva, M. U. S., Binota, J., Bose, P. L., Gupta, M., Sonam, P., Rana, P., et al. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1999439 · Cited by 20

RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)

Rehn, J. A., Mayoh, C., Heatley, S. L., McClure, B. J., Eadie, L. N., Schutz, C. E., Yeung, D. T. O., Cowley, M. J., Breen, J., & White, D. L. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010300 · Cited by 20

Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group

Kirtek, T. J., Chen, W., Laczko, D. I., Bagg, A., Koduru, P. R. K., Foucar, K. K., Venable, E. R., Nichols, M. M., Rogers, H. J., Tam, W., et al. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107309 · Cited by 20

Should Minimal Residual Disease Monitoring in Acute Lymphoblastic Leukemia be Standard of Care?

Campana, D. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0115-4 · Cited by 20

Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia

Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Harvey, R. C., et al. (2008) · Blood · doi:10.1182/blood.v112.11.427.427

Ikaros Deletions are Associated with Poor Prognosis in Acute Lymphoblastic Leukemia

Copland, M. (2009) · Future Oncology · doi:10.2217/fon.09.16 · Cited by 2

IKZF1 deletions predict a poor prognosis in children with B‐cell progenitor acute lymphoblastic leukemia: A multicenter analysis in Taiwan

Yang, Y., Hung, C., Chen, J., Lin, K., Jou, S., Hsiao, C., Sheen, J., Cheng, C., Wu, K., Lin, S., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02031.x · Cited by 60

ALL-456 Genomic Alterations in IKZF1 and Risk of Relapse in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Wang’ondu, R. W., Ashcraft, E., Chang, T., Roberts, K. G., Brady, S. W., Fan, Y., Evans, W., Relling, M. V., Crews, K. R., Yang, J. J., et al. (2024) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/s2152-2650(24)01114-5

IKZF1 (IKAROS) DELETIONS ARE INDEPENDENT ON THE PHILADELPHIA CHROMOSOME AND ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

IACOBUCCI, I., Lonetti, A., MARTINELLI, G., Ferrari, A., T., S. C., Chiaretti, S., Messina, M., Ottaviani, E., Guadagnuolo, V., Cilloni, D., et al. (2009) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)